Genmab — August 2017
-
@Forsent - CAR-T som trussel vs Genmabs Darzalex har været diskuteret rigtig mange gange. Prøv indledningsvis at søge i trådene. Den korte version kogt ned er, at der er mange bivirkninger og ikke umiddelbart henvender sig til Genmabs primære målgruppe. Der er langt igen. Efter hvad der er diskuteret virker det ikke umiddelbart som en direkte konkurrent.
-
"E L What do you see as the biggest competitor for Dara? Do you see CAR-T therapy as a serious threat?
Jan Van de Winkel There are not many active competitors for dara...
...l perhaps some of the 'new' checkpoint blockers could turn out to be active in the same therapeutic area, but we really view dara as a backbone treatment ie a drug that can be an ideal combination partner for other drugs... -
-
De benytter ikke det forbudte ord "cure" i dette skriv, men "A world without Multiple Myeloma
" http://files.shareholder.com/downloads/JNJ/3715498149x0x943349/2FD41076-855B-4DB6-B93F-5CF1B60340CF/A_World_Without_Multiple_Myeloma.pdf -
I forbindelse med prisen på Novartis CAR-T produkt kan jeg se at prisen er sat til 475.000 USD. http://www.fiercepharma.com/pharma/novartis-crosses-fda-finish-line-monumental-car-t-approval?utm_medium=nl&utm_source=internal&mrkid=41140432&mkt_tok=eyJpIjoiTlRFMk1UWTNNV0poWWpkaiIsInQiOiI2SERXZjM4TlhWdzZma3A0Q0djelo5VzNBVk4zbXVuMHZ6R2tSSkxwaVd4eEZab1lTYW1RcTAreXdDeHIzNHJoWk93UTZZRERIR1JZNXY2WldcL2ltTmgyU2d0U2FzdkZiYktna2Q5NkNoVVFpYWxDU2pJUVhaNENuUm1tdXpKREsifQ%3D%3D
-
-
God morgen.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind